SEC Filing Summary: Medasorb Technologies Corporation (8-K)
Business Context and Reporting Period
This Form 8-K was filed by Medasorb Technologies Corporation (not Cytosorbents Corp) on September 15, 2009, reporting events occurring on September 9, 2009. The filing serves as a Regulation FD disclosure regarding the company's participation in the Rodman & Renshaw Investor Conference held during the second week of September 2009.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report is a disclosure of presentation materials rather than a financial results report.
Material Changes
No material changes to financial performance or operations are reported in this document. The filing solely discloses the furnishing of presentation slides (Exhibit 99.1) used for investor communications.
Guidance, Outlook, and Risks
Management expects to participate in information sessions with analysts and investors. The presentation materials are furnished as Exhibit 99.1. The filing explicitly states that the information contained herein is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not subject to the liabilities of that section, nor is it incorporated by reference into other filings except as expressly set forth.
Key Facts for Investor Verification
- Verify the company name is Medasorb Technologies Corporation, not Cytosorbents Corp.
- Review Exhibit 99.1 (Slide presentation) for actual financial data or strategic outlook, as the 8-K text contains no numerical metrics.
- Note that the presentation materials are furnished, not filed, limiting their legal liability under Section 18 of the Exchange Act.
- Confirm the date of the investor conference was the second week of September 2009.